meddevicedb.com FDA Device Reference

Sensititre 18-24 hour MIC Breakpoint Susceptibility System with Plazomicin in the dilution range of 0.06-128 ug/mL

K181946 Class II Traditional
Decision Date
2018-08-08
Sponsor / Applicant
Thermo Fisher Scientific

Technical Specification

510(k) Submission ID K181946
Product Code JWY
Medical Specialty / Panel Microbiology
Regulation Citation 21 CFR 866.1640
Decision Date 2018-08-08
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

Sensititre 18-24 hour MIC Breakpoint Susceptibility System with Plazomicin in the dilution range of 0.06-128 ug/mL received FDA 510(k) clearance under submission number K181946, sponsored by Thermo Fisher Scientific. The device was reviewed via the Traditional premarket notification pathway and assigned to the Microbiology review panel. The statutory decision date of record is 2018-08-08.

Classification & Regulation

This clearance is catalogued under FDA product code JWY and 21 CFR 866.1640, within the Microbiology review panel as a Class II device.